4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-084893
Chief Commercial Officer sold 21,040 shares at $1.77 ($37,314)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piccina Cintia Chief Commercial Officer | 2022-08-01 | Sale | −21,040 | $1.77 | $37,314 | 34,824 | D |
| Open-market sales · 21,040 sh · avg $1.77 · $37,314 | |||||||
Loading xslF345X03/tm2222258d1_4seq.xml…